Edition:
Deutschland

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

40.71EUR
28 Oct 2020
Change (% chg)

-- (--)
Prev Close
€40.71
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,655,387
52-wk High
€78.34
52-wk Low
€40.30

About

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and... (more)

Buy/Sell

Sell Hold Buy
2.10 Mean rating from 29 analysts

Overall

Beta: 0.98
Market Cap(Mil.): €96,918.28
Shares Outstanding(Mil.): 826.95
Dividend: 2.70
Yield (%): 2.30

German stocks - Factors to watch on October 28

BERLIN/FRANKFURT, Oct 28The following are some of the factors that may move German stocks on Wednesday:

Photo

U.S. approves use of Bayer weed killer for five years

CHICAGO The U.S. Environmental Protection Agency said on Tuesday it will allow farmers to spray crops with weed killers based on the chemical dicamba that are sold by Bayer AG and other companies, after a U.S. appeals court blocked sales in June.

UPDATE 3-U.S. approves use of Bayer weed killer for five years

* Environmental groups sought ban on "drift" worries (Adds details, company comments)

U.S. EPA approves use of controversial Bayer weed killer for five years -RFD TV

CHICAGO, Oct 27 The U.S. Environmental Protection Agency will allow farmers for the next five years to spray crops with a Bayer AG weed killer that a U.S. appeals court blocked sales of in June, Administrator Andrew Wheeler said on RFD TV on Tuesday.

UPDATE 3-Covestro reports Q3 profit beat on strong Asia, furniture units

* Preliminary sales, EBITDA and outlook hike confirmed (Adds CEO comments from conference call)

UPDATE 2-Capgemini shares advance on better-than-expected Q3 growth

* Shares rise 6% and top French indices (Updates shares, adds CEO's comment)

REFILE-Chemicals maker Covestro Q3 profit beats on cost-cutting, demand recovery

Oct 27 German chemicals maker Covestro reported a better-than-expected third-quarter profit on Tuesday, citing cost-cutting measures, improved volumes in Asia-Pacific and demand recovery after a coronavirus-induced slump.

Photo

Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billion

FRANKFURT Bayer agreed to acquire unlisted U.S. biotech firm Asklepios BioPharmaceutical Inc for as much as $4 billion in a bet on gene therapy with the help of modified viruses.

Photo

Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billion

FRANKFURT Bayer agreed to acquire unlisted U.S. biotech firm Asklepios BioPharmaceutical Inc for as much as $4 billion (3.1 billion pounds) in a bet on gene therapy with the help of modified viruses.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.06%
Rohstoffe +0.03%
Industrie +0.02%
Konjunktur abhängige Waren & Dienstleistungen +0.07%
Konjunktur unabhängige Waren & Dienstleistungen +0.05%
Finanzindustrie +0.01%
Pharma +0.05%
Technologie +0.00%